International Journal of Health Research and Medico Legal Practice

Open Access Open Access  Restricted Access Subscription Access

Efficacy of Mefenamic Acid and Tranexamic Acid in the Management of Dysfunctional Uterine Bleeding


Affiliations
1 Department of Pharmacology, Kakatiya Medical College, Warangal, Telangana, India
2 Kakatiya Medical College, Warangal, India
 

Introduction: Dysfunctional uterine bleeding is one of the most commonly expressed complaints of women at reproductive age leads to anemia and its complications. This study compares the efficacy and acceptability of tranexamic acid with mefenamic acid in treating DUB in order to show the most effective drug. Materials and methods: During 2010-2011, 60 patients aged 15-49, with DUB who referred to Government maternity hospital, Hanmakonda, Warangal, were randomly divided into 2 thirty-patient groups. The first group received mefenamic acid and the other received tranexamic acid during the first three days of their period for 2 subsequent cycles; following that, their bleeding changes were evaluated. Results: Repeated measures anova analysis pointed out that while the decreasing pattern of bleeding for each drug was statistically significant (p value =0 /001), the difference between the decreasing pattern of bleeding resulted from the use of the two drugs was not significant (p=0/059). Both groups depicted the same level of satisfaction (p=0/079) and no serious complications were reported. Conclusion:The efficacy of mefenamic acid and teranexamic acid in treating menorrhagia was the same for both groups.

Keywords

DUB, Mefenamic Acid, Tranexamic Acid.
User
Notifications
Font Size

  • Royal College of GeneralPractitioners, office of Population Censuses and Surveys, Department of Health and Social Security. Morbidity From General Practice. London. Hmso, 1986.

  • LosiufaiL. Modern management of menorrhagia. Hong Kong Practitioner Feb 1996;18(2):12-15.

  • AbbottJa, Hawe J, Garry R. Quality of life should be considered the primary outcome for measuring success of endometrial ablation. J Assoc Gynecol Laparasc 2003;10;491-5.

  • BonnarJ,ShepparolBl, Treatment of menorrhagia during menstruation. Randomized controlled trial of Ethamsylate, Mefenamic Acid and Tranexamic Acid. Bmj 1996;313:579-82.

  • Hall BergL, Hogdahl A, Nilssonl. Menstrual blood loss. A population study. Variation at different ages and attempts to define normality. Acta Obstet Gynevol Scand 1996;45:320-510.

  • Warner Pe, Critchley Ho, Lwmsden Ma, Campbell Brown M, Douglas A, Murray Gd. Menorrhagia. Is the 80ml blood loss criterion useful in management of complaint of menorrhagia? Am J Obstet gynecology 2004;190:1224-9.

  • Berek, J.S. Berek And Novak Gynecology (15ed). 2012.

  • Janssen Ca, Scholtenpc, HeintrzAp. A simple visual assessment technique to discriminate between menorrhaghia and normal blood loss- Obset Gynecol 1995; 85; 977-82.

  • HagnesPj, Hedgson H, Anderson. Measurement of menstrual blood loss in patient complaining of menorrhagioa. Br J Obstet gynaecol 1977;84:763-8.

  • Bonnar J, Sheppard Bl. The haemostatic system and dysfunctional uterine bleeding. Research and Clinical 1983;5:27-36.

  • Wikipedia, The free encyclopedia, Tranexamic acid 2011 Http://En.Wikipedia.Org/Wiki/Tranexamic Acid.

  • Coulter A, Kelland J, Peto V, Rees Mc. Treating menorrhagia in primary care. An overview of drug trials and a survey of prescribing practice int J Tech assess health care 1995;11:456-71.

  • SukanyaSirilMd, Unnopjaisamram Md. Treatment of idiopatic menorrhagia with tranexamic acid, J Med Assocthai 2005;Vol 88.

  • Hall P, Maclachlin N, Thorn N. Control of menorrhagia by the cyclo-oxygenase. 1987;94:554-8.

  • Sekhavat L, Zare F, Karimzade M. Comparison of Mefenamic acid and Tranexamic acid in treatment of hypermenorrhea. ShahidSedugh University, Department of Obstet and Gynec oilyazd 2001-2005.

  • Shahraz S, Ghazianit. Tranexamic acid- Mefenamic acid. A Comprehensive Text book of Drug Information.


Abstract Views: 187

PDF Views: 80




  • Efficacy of Mefenamic Acid and Tranexamic Acid in the Management of Dysfunctional Uterine Bleeding

Abstract Views: 187  |  PDF Views: 80

Authors

M. Damadari Bai
Department of Pharmacology, Kakatiya Medical College, Warangal, Telangana, India
M. Purna Chandrakala
Kakatiya Medical College, Warangal, India

Abstract


Introduction: Dysfunctional uterine bleeding is one of the most commonly expressed complaints of women at reproductive age leads to anemia and its complications. This study compares the efficacy and acceptability of tranexamic acid with mefenamic acid in treating DUB in order to show the most effective drug. Materials and methods: During 2010-2011, 60 patients aged 15-49, with DUB who referred to Government maternity hospital, Hanmakonda, Warangal, were randomly divided into 2 thirty-patient groups. The first group received mefenamic acid and the other received tranexamic acid during the first three days of their period for 2 subsequent cycles; following that, their bleeding changes were evaluated. Results: Repeated measures anova analysis pointed out that while the decreasing pattern of bleeding for each drug was statistically significant (p value =0 /001), the difference between the decreasing pattern of bleeding resulted from the use of the two drugs was not significant (p=0/059). Both groups depicted the same level of satisfaction (p=0/079) and no serious complications were reported. Conclusion:The efficacy of mefenamic acid and teranexamic acid in treating menorrhagia was the same for both groups.

Keywords


DUB, Mefenamic Acid, Tranexamic Acid.

References